ATE364387T1 - Zellbasierte gentherapie für das lungensystem - Google Patents

Zellbasierte gentherapie für das lungensystem

Info

Publication number
ATE364387T1
ATE364387T1 AT99944205T AT99944205T ATE364387T1 AT E364387 T1 ATE364387 T1 AT E364387T1 AT 99944205 T AT99944205 T AT 99944205T AT 99944205 T AT99944205 T AT 99944205T AT E364387 T1 ATE364387 T1 AT E364387T1
Authority
AT
Austria
Prior art keywords
cell
based gene
gene therapy
patient
circulation
Prior art date
Application number
AT99944205T
Other languages
English (en)
Inventor
Duncan Stewart
Original Assignee
An Go Gen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by An Go Gen Inc filed Critical An Go Gen Inc
Application granted granted Critical
Publication of ATE364387T1 publication Critical patent/ATE364387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99944205T 1999-09-23 1999-09-23 Zellbasierte gentherapie für das lungensystem ATE364387T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1999/000869 WO2001021184A1 (en) 1999-09-23 1999-09-23 Cell-based gene therapy for the pulmonary system

Publications (1)

Publication Number Publication Date
ATE364387T1 true ATE364387T1 (de) 2007-07-15

Family

ID=4173386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944205T ATE364387T1 (de) 1999-09-23 1999-09-23 Zellbasierte gentherapie für das lungensystem

Country Status (11)

Country Link
EP (2) EP1220679B1 (de)
JP (1) JP2003509463A (de)
AT (1) ATE364387T1 (de)
AU (1) AU5724499A (de)
BR (1) BR9917500A (de)
CA (1) CA2383093A1 (de)
DE (1) DE69936320T2 (de)
ES (1) ES2546937T3 (de)
IL (3) IL148826A0 (de)
MX (1) MXPA02003131A (de)
WO (1) WO2001021184A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11975030B2 (en) 2019-03-19 2024-05-07 Figene, Llc Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
JPH04507041A (ja) * 1988-12-13 1992-12-10 アメリカ合衆国 遺伝工学により修飾された内皮細胞およびその利用方法
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
WO1992015676A1 (en) * 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Somatic cell gene therapy
WO1993013807A1 (en) * 1992-01-10 1993-07-22 Georgetown University A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
CA2086844A1 (en) * 1993-01-07 1994-07-08 Ian D. Dube Method and product of gene transfer into cells
CA2260771A1 (en) * 1996-07-17 1998-01-22 The General Hospital Corporation Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene
ATE287271T1 (de) * 1996-11-01 2005-02-15 Ark Therapeutics Ltd Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US6147109A (en) * 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
JP2002502608A (ja) * 1998-02-06 2002-01-29 コラテラル・セラピューティックス・インコーポレイテッド 血管新生促進因子である血管内皮細胞成長因子：ｖｅｇｆの変異体
CA2266805C (en) * 1998-03-27 2015-04-28 An-Go-Gen Inc. Cell-based gene therapy in the treatment of pulmonary disorders
CA2227425A1 (en) * 1998-03-27 1999-09-27 An-Go-Gen Inc. Cell-based gene therapy

Also Published As

Publication number Publication date
EP1220679B1 (de) 2007-06-13
EP1220679A1 (de) 2002-07-10
EP1839667A3 (de) 2010-04-14
IL148826A (en) 2010-12-30
CA2383093A1 (en) 2001-03-29
IL148826A0 (en) 2002-09-12
IL192893A0 (en) 2009-02-11
JP2003509463A (ja) 2003-03-11
DE69936320D1 (de) 2007-07-26
BR9917500A (pt) 2002-05-21
EP1839667B1 (de) 2015-06-17
ES2546937T3 (es) 2015-09-30
IL192893A (en) 2014-03-31
EP1839667A2 (de) 2007-10-03
MXPA02003131A (es) 2003-08-20
WO2001021184A1 (en) 2001-03-29
AU5724499A (en) 2001-04-24
DE69936320T2 (de) 2008-02-21

Similar Documents

Publication Publication Date Title
ATE385810T1 (de) Verwendung von dna oder rna zur herstellung eines medikaments zur behandlung von tumoren
NZ505011A (en) Expression vectors and cell lines expressing VEGF-D and method of treating melanomas
SE9702860L (sv) Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
DE69331526D1 (de) Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
EP0235162A4 (de) Cdns und gen für menschliches angiogenin (angiogenesis-faktor) und expression.
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
SE8703625D0 (sv) New medical use
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
NZ223506A (en) Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
NO963742L (no) Fremgangsmåte til å stimulere hematopoese med hemaglobin
ATE420156T1 (de) Methode zur einführung von genetischem material in zellen
AU5464000A (en) Recombinant adenoviral vectors for cell specific infection and genome integration and expressing chimeric fiber proteins
NZ505063A (en) Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions
GR3026602T3 (en) Morphogen-induced liver regeneration.
MD545G2 (ro) Preparat medicamentos
ATE364387T1 (de) Zellbasierte gentherapie für das lungensystem
El-Batouty et al. Comparative evaluation of the effects of ultrasonic and ultraviolet irradiation on tissue regeneration
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
NZ335401A (en) Therapeutic uses of BPI protein products in cystic fibrosis patients
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
ATE120491T1 (de) Ausgeglichenes, konstitutives, induzierbares transkriptionssystem.
WO2000017375A3 (en) Method to treat haemophilia by in vivo gene therapy with retroviral vectors
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
GB0202410D0 (en) Treatment of IL deficiencies
GB8727493D0 (en) Epidermal growth factor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220679

Country of ref document: EP